Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc. (CRNX) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · CRNX · as of Mar 31, 2025
Ownership Breakdown
230
Institutional Holders
▼ 22 vs Q4
$3.42B
Total Inst. Value
▼ $1.68B vs Q4
105.44M
Shares Outstanding
freeFloat 93.01%
101.90M
13F Shares Held
▲ 2.20M vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
CRNX largest shareholders · institutional ownership
Q1 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
FMR LLC pharmaceutical preparations | 14.03M | 15.07% | 15.07% | $470.61B | May 12, 2025 | ▲ 5.10M |
VANGUARD GROUP INC pharmaceutical preparations | 9.31M | 10.00% | 10.00% | $312.31B | May 9, 2025 | ▲ 222.2K |
BLACKROCK, INC. pharmaceutical preparations | 7.66M | 8.22% | 8.22% | $256.80B | May 2, 2025 | ▲ 141.4K |
WELLINGTON MANAGEMENT GROUP LLP pharmaceutical preparations | 6.89M | 7.40% | 7.40% | $231.14B | May 13, 2025 | ▼ 59.2K |
DRIEHAUS CAPITAL MANAGEMENT LLC pharmaceutical preparations | 6.24M | 6.70% | 6.70% | $209.29B | May 15, 2025 | ▲ 98.9K |
PRICE T ROWE ASSOCIATES INC /MD/ pharmaceutical preparations | 5.11M | 5.49% | 5.49% | $171.47B | May 14, 2025 | ▼ 302.1K |
FARALLON CAPITAL MANAGEMENT LLC pharmaceutical preparations | 4.61M | 4.95% | 4.95% | $154.45B | May 15, 2025 | ▲ 530.0K |
ECOR1 CAPITAL, LLC pharmaceutical preparations | 4.29M | 4.61% | 4.61% | $143.82B | May 15, 2025 | — held |
JANUS HENDERSON GROUP PLC pharmaceutical preparations | 3.42M | 3.68% | 3.68% | $118.90B | May 15, 2025 | ▲ 629.0K |
STATE STREET CORP pharmaceutical preparations | 3.28M | 3.53% | 3.53% | $110.12B | May 15, 2025 | ▲ 292.4K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2025 vs prior quarter
Q1 2025
26
Increased
+10.34M shares4
New Positions
first time holders18
Decreased
−5.08M shares0
Sold Out
fully exitedNet shares change (top 50)
+5.27M
+10.34M / −5.08M
Net new holders
+12
4 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
CRNX insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
3
Buy transactions
4
Sell transactions
0.75
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Struthers Richard Scott President & CEO | May 29, 2026 | Gift | 222,200 | — | — | 627.0K | Form 4 ↗ |
Struthers Richard Scott President & CEO | May 29, 2026 | Gift | 111,100 | — | — | 515.9K | Form 4 ↗ |
Struthers Richard Scott President & CEO | May 29, 2026 | Gift | 222,200 | — | — | 439.0K | Form 4 ↗ |
Struthers Richard Scott President & CEO | May 29, 2026 | Gift | 111,100 | — | — | 404.8K | Form 4 ↗ |
Struthers Richard Scott President & CEO | May 29, 2026 | Gift | 222,200 | — | — | 223.2K | Form 4 ↗ |
Struthers Richard Scott President & CEO | May 29, 2026 | Gift | 222,200 | — | — | 216.8K | Form 4 ↗ |
Struthers Richard Scott President & CEO | May 29, 2026 | Gift | 80,000 | — | — | 136.8K | Form 4 ↗ |
Struthers Richard Scott President & CEO | May 29, 2026 | Gift | 111,100 | — | — | 112.1K | Form 4 ↗ |
Struthers Richard Scott President & CEO | May 29, 2026 | Gift | 111,100 | — | — | 111.1K | Form 4 ↗ |
Struthers Richard Scott President & CEO | May 29, 2026 | Gift | 80,000 | — | — | 80.0K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Crinetics Pharmaceuticals, Inc. (CRNX) is primarily owned by institutional investors, who hold approximately 96.7% of total shares outstanding. Company insiders own approximately 6.99%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of Crinetics Pharmaceuticals, Inc. is FMR LLC, holding approximately 14.03 million shares — equal to 15.07% of outstanding shares — as of March 31, 2025.
A total of 230 institutional investors currently hold CRNX stock, with a combined institutional value of approximately $3.42 billion as of the most recent 13F filing period.
Frequently asked questions
CRNX ownershipCrinetics Pharmaceuticals, Inc. (CRNX) is primarily owned by institutional investors, who hold approximately 96.7% of shares. The largest shareholder is FMR LLC with a 15.07% stake. Company insiders hold 6.99%. Data sourced from SEC Form 13F as of March 31, 2025.